AddLife is a Swedish Medtech company active on the European market. AddLife owns and acquires companies in niche segments with offerings aimed primarily at the healthcare sector, from research to medical care.
The head office is located in Stockholm.
2016
Served areaWorldwide
HeadquartersBrunkebergstorg 5, 10362 Stockholm – Sweden
Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Assets | N/A | 4,149,600,000.00 | 10,596,000,000.00 | 13,057,000,000.00 |
Noncurrent Assets | N/A | 2,457,200,000.00 | 7,845,000,000.00 | 9,485,000,000.00 |
Property Plant And Equipment | N/A | 433,600,000.00 | 627,000,000.00 | 899,000,000.00 |
Noncurrent Receivables | N/A | 7,000,000.00 | 7,000,000.00 | 85,000,000.00 |
Deferred Tax Assets | N/A | 5,000,000.00 | 11,000,000.00 | 51,000,000.00 |
Other Noncurrent Financial Assets | N/A | 8,800,000.00 | 9,000,000.00 | 10,000,000.00 |
Current Assets | N/A | 1,692,400,000.00 | 2,751,000,000.00 | 3,572,000,000.00 |
Inventories | N/A | 640,200,000.00 | 1,189,000,000.00 | 1,646,000,000.00 |
Current Tax Assets Current | N/A | 300,000.00 | 24,000,000.00 | 78,000,000.00 |
Cash and cash equivalents | 99,100,000.00 | 216,000,000.00 | 345,000,000.00 | 376,000,000.00 |
Equity And Liabilities | N/A | 4,149,600,000.00 | 10,596,000,000.00 | 13,057,000,000.00 |
Equity | 1,476,200,000.00 | 1,889,000,000.00 | 4,291,000,000.00 | 4,971,000,000.00 |
Issued Capital | N/A | 58,300,000.00 | 62,000,000.00 | 62,000,000.00 |
Retained Earnings | N/A | 739,000,000.00 | 1,547,000,000.00 | 1,787,000,000.00 |
Share Premium | N/A | 1,134,300,000.00 | 2,654,000,000.00 | 2,642,000,000.00 |
Other Reserves | N/A | -49,500,000.00 | 22,000,000.00 | 477,000,000.00 |
Equity Attributable To Owners Of Parent | N/A | 1,882,100,000.00 | 4,285,000,000.00 | 4,968,000,000.00 |
Noncontrolling Interests | N/A | 8,200,000.00 | 6,000,000.00 | 3,000,000.00 |
Liabilities | N/A | 2,259,300,000.00 | 6,305,000,000.00 | 8,086,000,000.00 |
Noncurrent Liabilities | N/A | 514,300,000.00 | 1,393,000,000.00 | 3,630,000,000.00 |
Noncurrent Provisions | N/A | 29,500,000.00 | 32,000,000.00 | 134,000,000.00 |
Noncurrent Provisions For Employee Benefits | N/A | 80,500,000.00 | 82,000,000.00 | 60,000,000.00 |
Deferred Tax Liabilities | N/A | 161,500,000.00 | 489,000,000.00 | 459,000,000.00 |
Other Noncurrent Financial Liabilities | N/A | 99,600,000.00 | 564,000,000.00 | 2,744,000,000.00 |
Other Noncurrent Liabilities | N/A | 1,200,000.00 | 2,000,000.00 | 8,000,000.00 |
Current Liabilities | N/A | 1,745,000,000.00 | 4,912,000,000.00 | 4,456,000,000.00 |
Current Provisions | N/A | 9,400,000.00 | 10,000,000.00 | 52,000,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 648,800,000.00 | 796,000,000.00 | 957,000,000.00 |
Current Tax Liabilities Current | N/A | 81,100,000.00 | 110,000,000.00 | 70,000,000.00 |
Other Current Financial Liabilities | N/A | 473,000,000.00 | 3,194,000,000.00 | 2,491,000,000.00 |
Other Current Liabilities | N/A | 231,400,000.00 | 301,000,000.00 | 268,000,000.00 |
Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|
Revenue | 5,273,300,000.00 | 7,993,000,000.00 | 9,084,000,000.00 |
Other Income | 84,300,000.00 | 100,000,000.00 | 218,000,000.00 |
Profit Loss From Operating Activities | 672,500,000.00 | 996,000,000.00 | 808,000,000.00 |
Finance Income | 700,000.00 | 97,000,000.00 | 445,000,000.00 |
Finance Costs | 14,200,000.00 | 166,000,000.00 | 651,000,000.00 |
Profit Loss Before Tax | 659,000,000.00 | 927,000,000.00 | 602,000,000.00 |
Income Tax Expense Continuing Operations | 139,300,000.00 | 206,000,000.00 | 119,000,000.00 |
Profit (loss) | 519,700,000.00 | 721,000,000.00 | 483,000,000.00 |
Profit Loss Attributable To Owners Of Parent | 517,800,000.00 | 719,000,000.00 | 480,000,000.00 |
Profit Loss Attributable To Noncontrolling Interests | 1,900,000.00 | 2,000,000.00 | 3,000,000.00 |
Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Profit (loss) | N/A | 519,700,000.00 | 721,000,000.00 | 483,000,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | -119,100,000.00 | 53,000,000.00 | -88,000,000.00 |
Adjustments For Decrease Increase In Other Operating Receivables | N/A | -170,600,000.00 | 18,000,000.00 | 64,000,000.00 |
Adjustments For Increase Decrease In Other Operating Payables | N/A | 397,400,000.00 | -185,000,000.00 | -97,000,000.00 |
Other Adjustments For Noncash Items | N/A | 280,400,000.00 | 449,000,000.00 | 684,000,000.00 |
Income Taxes Paid Refund Classified As Operating Activities | N/A | 97,000,000.00 | 252,000,000.00 | 256,000,000.00 |
Cash Flows From Used In Operating Activities | N/A | 950,100,000.00 | 1,010,000,000.00 | 909,000,000.00 |
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | 0.00 | 0.00 |
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 345,100,000.00 | 2,843,000,000.00 | 818,000,000.00 |
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 7,800,000.00 | 9,000,000.00 | 13,000,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 62,700,000.00 | 101,000,000.00 | 213,000,000.00 |
Proceeds From Sales Of Intangible Assets Classified As Investing Activities | N/A | 800,000.00 | 0.00 | 1,000,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 29,500,000.00 | 42,000,000.00 | 69,000,000.00 |
Cash Flows From Used In Investing Activities | N/A | -428,700,000.00 | -2,977,000,000.00 | -1,086,000,000.00 |
Payments To Acquire Or Redeem Entitys Shares | N/A | 19,300,000.00 | 0.00 | 60,000,000.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | 265,200,000.00 | 2,649,000,000.00 | 1,416,000,000.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 614,400,000.00 | 260,000,000.00 | 846,000,000.00 |
Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | -3,300,000.00 | -121,000,000.00 | -160,000,000.00 |
Cash Flows From Used In Financing Activities | N/A | -372,500,000.00 | 2,070,000,000.00 | 134,000,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 148,900,000.00 | 103,000,000.00 | -43,000,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -32,000,000.00 | 26,000,000.00 | 74,000,000.00 |
Cash and cash equivalents | 99,100,000.00 | 216,000,000.00 | 345,000,000.00 | 376,000,000.00 |
Please note that some sums might not add up.
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
07.03.24 | Håkan Roos | Other | Buy | SEK 31,849,476.22 |
20.02.24 | Christina Rubenhag | Other | Buy | SEK 51,400.00 |
21.12.23 | Håkan Roos | Other | Buy | SEK 521,431.75 |
24.11.23 | Fredrik Dalborg | Other | Buy | SEK 89,950.00 |
23.11.23 | Anna Isoz Dalborg | Other | Buy | SEK 49,911.40 |
02.11.23 | Märta Isoz Dalborg | Other | Buy | SEK 1,540.35 |
25.09.23 | Håkan Roos | Other | Buy | SEK 290,970.00 |
18.09.23 | Fredrik Dalborg | Other | Buy | SEK 207,990.00 |
12.05.23 | Fredrik Dalborg | Other | Buy | SEK 129,400.00 |
24.03.23 | Fredrik Dalborg | Other | Buy | SEK 139,200.00 |
SE0014401378
LEI5493005T3M7CD7XWE013
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.